MMR uptake hits new highs in U.K.; BARDA expands vaccine contract with Pfenex;

> The proportion of British kids receiving the MMR vaccine has hit new highs. Article

> BARDA has added up to $8 million in funding to its anthrax vaccine contract with Pfenex. Release

> Advanced BioScience Laboratories is manufacturing a Shigella vaccine candidate for PATH. Item

Research into a cat AIDS virus protein has shown a possible way to develop a human vaccine. News

> Schools in North Carolina have suspended hundreds of students for failing to get vaccinated. Piece

> WHO has recommended a strain of H7N9 for use in development of vaccines. Statement (PDF)

> The U.S. military is planning clinical trials of vaccines against ovarian and uterine cancers. Feature

> Europe has given $8 million to a consortium developing a vaccine for human hookworm. Release

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.